TY - JOUR
T1 - Parent disclosure of complementary health approaches used for children with autism spectrum disorder
T2 - Barriers and facilitators
AU - Lindly, Olivia
AU - Thorburn, Sheryl
AU - Heisler, Karen
AU - Reyes, Nuri
AU - Zuckerman, Katharine
N1 - Funding Information:
This research was supported by the Agency for Healthcare Research and Quality grant # 5T32HS000063-24, by the Ruth Warnke Graduate Fellowship from Oregon State University, and by the National Institute of Mental Health grant # K23MH095828. We thank Lorraine Ball, Dr. Adam Branscum, Dr. Joseph Catania, Dr. Kari-Lyn Sakuma, and Dr. Emily Ho for their feedback on the research reported. We also thank Dr. Ann Reynolds and Dr. Kathryn Smith for their assistance with the submission of research protocol materials to their respective Institutional Review Boards.
Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2017/12
Y1 - 2017/12
N2 - Background and objectives Complementary health approaches (CHA) are widely used among children with autism spectrum disorder (ASD). As part of shared treatment decision-making, healthcare providers are encouraged to discuss CHA with parents of children with ASD. Yet prior research suggests that parents often do not disclose CHA used for children, and their reasons for nondisclosure are poorly understood. We, therefore, aimed to identify barriers and facilitators to parent disclosure of CHA used for children with ASD. Design and setting In-depth interviews were conducted with 31 parents who reported that they were currently using CHA for their child's ASD in Denver, Colorado or Portland, Oregon. Results We used content analysis to identify six main themes indicating that the following factors play a role in disclosure: parents’ drive to optimize their child's health, parent self-efficacy discussing CHA with healthcare providers, parent beliefs about the effectiveness of CHA, parent-provider relationship quality, provider attitudes and knowledge regarding CHA and ASD, and visit characteristics. Conclusions Study findings suggest that family and health system factors, together, influence parent disclosure of CHA used for children with ASD. Multifaceted intervention concurrently targeting the CHA-related knowledge, beliefs, and self-efficacy of parents whose children have been recently diagnosed with ASD, in addition to the CHA-related attitudes and knowledge of their healthcare providers may promote disclosure and shared treatment decision-making about the use of CHA.
AB - Background and objectives Complementary health approaches (CHA) are widely used among children with autism spectrum disorder (ASD). As part of shared treatment decision-making, healthcare providers are encouraged to discuss CHA with parents of children with ASD. Yet prior research suggests that parents often do not disclose CHA used for children, and their reasons for nondisclosure are poorly understood. We, therefore, aimed to identify barriers and facilitators to parent disclosure of CHA used for children with ASD. Design and setting In-depth interviews were conducted with 31 parents who reported that they were currently using CHA for their child's ASD in Denver, Colorado or Portland, Oregon. Results We used content analysis to identify six main themes indicating that the following factors play a role in disclosure: parents’ drive to optimize their child's health, parent self-efficacy discussing CHA with healthcare providers, parent beliefs about the effectiveness of CHA, parent-provider relationship quality, provider attitudes and knowledge regarding CHA and ASD, and visit characteristics. Conclusions Study findings suggest that family and health system factors, together, influence parent disclosure of CHA used for children with ASD. Multifaceted intervention concurrently targeting the CHA-related knowledge, beliefs, and self-efficacy of parents whose children have been recently diagnosed with ASD, in addition to the CHA-related attitudes and knowledge of their healthcare providers may promote disclosure and shared treatment decision-making about the use of CHA.
KW - Autism spectrum disorder
KW - Complementary and alternative medicine
KW - Complementary health approaches
KW - Disclosure
KW - Shared treatment decision-making
UR - http://www.scopus.com/inward/record.url?scp=85029499366&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029499366&partnerID=8YFLogxK
U2 - 10.1016/j.ctim.2017.09.003
DO - 10.1016/j.ctim.2017.09.003
M3 - Article
C2 - 29154066
AN - SCOPUS:85029499366
SN - 0965-2299
VL - 35
SP - 47
EP - 52
JO - Complementary Therapies in Medicine
JF - Complementary Therapies in Medicine
ER -